CCRM

What can we expect for science under a Trump or Harris presidency? https://www.signalsblog.ca/right-turn-science-in-the-u-s-under-donald-trump-and-kamala-harris/

Here are some fun pics from our "random acts of kindness" team-building event. It was so much fun and a great day spent with wonderful colleagues.

There was so much to say about strategic management of your intellectual property portfolio in regenerative medicine we needed a part 2.

https://www.signalsblog.ca/strategic-ip-management-in-rm-enhancing-innovation-and-overcoming-patent-challenges/

https://www.warpnews.org/health-tech/ai-designed-proteins-work-in-stem-cell-study-2/

🦾 AI-designed proteins work in stem cell study AI-designed proteins have successfully transformed stem cells into blood vessel cells. The proteins helped build regenerative tissues and worked in animal transplants. The technology can potentially be used to repair damaged tissue and treat diseases.

The role and impact of intellectual property rights on innovation and investment in regenerative medicine. https://www.signalsblog.ca/the-role-and-impact-of-ip-rights-on-innovation-and-investment-in-rm/

Image: f1000

cc: Norton Rose Fulbright

CCRM CCRM supports the development of regenerative medicines and associated enabling technologies.

It’s back and we’re celebrating 16 years of Cells I See!

The 2024 Cells I See art contest is accepting cell images and artwork submissions from now until September 6, 2024. Cells I See is about the beauty of cells seen directly through the microscope or through the interpretive lens of the artist.

Hosted by CCRM and the Stem Cell Network - Réseau de cellules souches, the Cells I See contest will award the Grand Prize winner $750. Entries will be blind judged for the $750 Grand Prize at the 2024 Till & McCulloch Meetings, taking place in Montreal in November. Based on the outcome of online voting on CCRM’s page – more details to follow – a People’s Choice prize of $500 will also be issued.

For full contest rules, submission instructions and to view past submissions, check out the Cells I See website at the following link: https://cellsisee.ccrm.ca/

Image: “Road to Regeneration” by Ahmad Galuta, University of Ottawa

CCRM CCRM supports the development of regenerative medicines and associated enabling technologies.

Sign up for free to get 24 hours of inspiring, innovative and empowering content from at
Phacilitate Evnt. CCRM's Sven Kili, Chief Development Officer, is on a panel July 10 at 8 p.m. EDT.

Women in Advanced Therapies Global - womeninadvancedtherapies.com Confirmed Partners

Learn how the side effects of for can be alleviated with , in this new blog post from one of our medical writers.

https://www.signalsblog.ca/combating-side-effects-of-chemotherapy-with-regenerative-medicine/


Image source: vecteezy.com

CCRM CCRM supports the development of regenerative medicines and associated enabling technologies.

A warning to stem cell clinics to stop marketing "treatments" that are not approved, and a reminder to consumers to be wary and do your research. At the very least, unapproved therapies can be expensive; sadly they can also be dangerous. The industry is making exciting progress, but good science takes time and a stem cell isn't a magic bullet for every type of health problem.

Lung Institute found guilty of selling patients 'sham' stem cell treatment for incurable lung disease The jury verdict against the Lung Institute is one of the costliest judgments against a for-profit stem cell clinic in U.S. history.

Happy Canada Day!

(We hope this message won't be as polarizing as our last post.)

Image: Vecteezy.com

! Our latest blog post is about and and includes stories about, and from, well-known figures and biopharma leaders; stats; resources; scholarship info; and more.

EngiQueers Canada, Royal Canadian Institute for Science, Pride at Work Canada / Fierté au travail Canada, J. Craig Venter Institute, Pride in STEM

Image: Ylanite Koppens

https://www.signalsblog.ca/right-turn-stem-and-pride/

CCRM CCRM supports the development of regenerative medicines and associated enabling technologies.

Would you eat cultivated meat?

Ever After Foods Nabs $10M to Make Cultivated Meat 90% Cheaper Ever After Foods has secured $10M for its bioreactor platform to let companies scale up cultivated meat production at 90% lower costs.

Here's another interesting issue of "Regenerative medicine news under the microscope" https://www.signalsblog.ca/regenerative-medicine-news-under-the-microscope-may-2024/

, ,
BlueRock Therapeutics, Aspen Neuroscience, California Institute for Regenerative Medicine

CCRM CCRM supports the development of regenerative medicines and associated enabling technologies.

https://apnews.com/article/stem-cell-fraud-lawsuit-23789b100f28a9abda6e287773369790

Some hawking stem cells say they can treat almost anything. They can't Attorneys general across the U.S. have a new fight on their hands: protecting Americans from unproven and expensive stem cell treatments that salespeople claim can cure almost anything.

This resource is helpful if you follow the cell and gene therapy approvals space in Canada and internationally. Bookmark it!

Public Health Agency of Canada, American Society of Gene & Cell Therapy, Citeline

https://www.signalsblog.ca/cell-and-gene-therapies-approved-by-health-canada-and-global-regulators/

CCRM CCRM supports the development of regenerative medicines and associated enabling technologies.

Thank you for the opportunity to comment!

Using iPSCs as Starting Material for Advanced Therapies Advanced therapies are on a long-term journey towards using induced pluripotent stem cells as their starting cells.

Analysis of investment patterns in regenerative medicine startups. Read it here: https://www.signalsblog.ca/analysis-of-investment-patterns-in-regenerative-medicine-startups/

Image source Alliance for Regenerative Medicine

CCRM CCRM supports the development of regenerative medicines and associated enabling technologies.

We’re pleased to share that our “Commercializing Living Therapies with CCRM” podcast has reached over 2,500 downloads! 🎉 Thank you for listening! Over three seasons we have shared insider insights, trends and valuable information for professionals in the cell and gene therapy industry. A big thank you to our guests (experts!). We couldn't have done this without you.

Get caught up here https://lnkd.in/daTWUkEF or wherever you stream podcasts.

CCRM CCRM supports the development of regenerative medicines and associated enabling technologies.

It’s back and we’re celebrating 16 years of Cells I See!

The 2024 Cells I See art contest is accepting cell images and artwork submissions from now until September 6, 2024. Cells I See is about the beauty of cells seen directly through the microscope or through the interpretive lens of the artist.

Hosted by CCRM and Stem Cell Network - Réseau de cellules souches, the Cells I See contest will award the Grand Prize winner $750. Entries will be blind judged for the $750 Grand Prize at the 2024 Till & McCulloch Meetings, taking place in Montreal in November. Based on the outcome of online voting on CCRM’s page - watch for more details - a People’s Choice prize of $500 will also be issued.

For full contest rules, submission instructions and to view past submissions, check out the Cells I See website at the following link: https://cellsisee.ccrm.ca/

Image below: "Neural Networks in Living Colour" by Nuwan Hettige, PhD

McMaster University is being recognized for its growing and successful life sciences ecosystem. Congratulations!

We have been working with McMaster since we launched over a decade ago and our relationship has become stronger since choosing McMaster Innovation Park as the location for our CDMO subsidiary . With so much talent to draw from, it was an easy decision.

https://hamiltoncitymagazine.ca/coming-to-life-at-mcmaster-university/

cc: City of Hamilton

Coming to life at McMaster University - Hamilton City Magazine A dynamic network of startups coming out of academic research – along with an eye-popping takeover of a homegrown success story – is fuelling Hamilton’s rise as a national biotech capital. A $2.4-billion takeover of local startup Fusion Pharmaceuticals is showing how McMaster University and Ha...

A large team from CCRM and attended ISCT's annual meeting in Vancouver last week. We heard the latest in the science of cell and gene therapies, progress in translating them to the clinic, and we also presented posters and gave talks. ISCT celebrated its 30 anniversary and we've been attending the meeting for the last decade. Here are some photos of the conference, Vancouver's waterfront and Grouse Mountain - the location for the industry networking event CCRM co-hosted with STEMCELL Technologies and the UK's Cell and Gene Therapy Catapult.

Spinal cord injury has proven challenging to treat with stem cell therapy. But there's hope.

https://www.signalsblog.ca/pluripotent-stem-cell-clinical-trials-for-sci-is-the-target-of-a-moonshot-consortium/

cc: University of British Columbia, University of Victoria, Tufts University, California Institute for Regenerative Medicine, Lineage Cell Therapeutics, Nserc Canada

CCRM CCRM supports the development of regenerative medicines and associated enabling technologies.

Curious to know what big news and studies in the world came out in April? We've got you covered. Read the post about and .

https://www.signalsblog.ca/regenerative-medicine-news-under-the-microscope-april-2024/

CCRM CCRM supports the development of regenerative medicines and associated enabling technologies.

From our partners at the Ottawa Hospital Research Institute.

Aging is inevitable, but a study in Aging Cell suggests cardiovascular disease might not be. Arteries harden and accumulate plaque with age, but the molecular mechanisms behind these changes are not well understood. Dr. William Stanford and Dr. Michael J. Hendzel led a study that monitored the molecular changes in human blood vessel wall cells as they aged in a lab. To study the aging process, cells were generated from induced pluripotent stem cells (iPSCs) that came from people with a rapid aging condition called Progeria. The team found that an epigenetic change to the cell’s genetic material (a decrease in histone H4K16 acetylation) played a key role in the hardening of arteries. They confirmed this molecular change also happens in the blood vessel wall cells of people with cardiovascular disease. “These cells could help us uncover potential drugs to prevent or treat cardiovascular diseases by targeting these molecular changes,” said Dr. Stanford.

On Wed., May 29, Sadegh Davoudi, PhD, Lead Scientist, CCRM, will be presenting a talk called “Adaptable Automation: Streamlining Experimental Workflows” at Laboratory Robotics and Information Group (LRIG) Canada’s spring event. This free event offers both virtual and in-person options for attendance. The in-person option takes place at Toronto’s BMO Education & Conference Centre.

Learn more and register here: https://www.eventbrite.com/e/lrig-toronto-2024-spring-event-tickets-861627409777